When should case-only designs be used for safety monitoring of medical products?
نویسندگان
چکیده
منابع مشابه
High-dose statins should only be used in atherosclerotic strokes.
Statin therapy should not be initiated in this patient, a young woman free of vascular risk factors and at low risk for atherosclerotic cerebrovascular disease. Unfortunately, this patient has an iatrogenic stroke after a cardiac catheterization performed for symptoms described as “atypical.” There is no evidence that underlying atherosclerotic disease accounted for her cardiac symptoms or stro...
متن کاملComponent resolved diagnosis: when should it be used?
The knowledge on molecular allergy diagnosis is continuously evolving. It is now time for the clinician to integrate this knowledge and use it when needed to improve the accuracy of diagnosis and thus provide more precise therapeutic and avoidance measures. This review does not intend to comprehensively analyze all the available allergen molecules, but to provide some practical clues on use and...
متن کاملWhen Should Screening and Surveillance Be Used during Pregnancy?
Using the ethical and legal concept of shared responsibility for healthy births, this article considers social, cultural, and historical contexts in which medicalization and criminalization have worked in tandem to widen surveillance in ways that intensify scrutiny of women's lives under the guise of child protection, bringing women who are pregnant, postpartum, or parenting under criminal just...
متن کاملWhich Graphical Approaches should be Used to Represent Medical Knowledge?
Medical knowledge is growing both in quantity and complexity. Although sources of medical knowledge have been digitalized, the way the knowledge they contain is presented to users has not changed and is still highly text-based. However, it has been shown that this information could be presented more efficiently using graphical approaches, such as graphical languages and information visualizatio...
متن کاملShould levodopa be used anymore?
Levodopa is the most potent dopaminergic oral drug available in clinical practice. After chronic treatment, many patients with Parkinson's disease develop dyskinesia and motor fluctuations which are difficult to manage. It was hoped that introduction of dopaminergic agonists could diminish these side effects while keeping the same efficacy as levodopa. Prospective clinical data do not support t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacoepidemiology and Drug Safety
سال: 2012
ISSN: 1053-8569
DOI: 10.1002/pds.2330